We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$91.2M
AUM Growth
-$8.8M
(-8.8%)
Cap. Flow
-$6.5M
Cap. Flow
% of AUM
-7.12%
Top 10 Holdings %
Top 10 Hldgs %
34.95%
Holding
120
New
8
Increased
15
Reduced
40
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ooma
OOMA
|
+$986K |
| 2 |
Integer Holdings
ITGR
|
+$951K |
| 3 |
CRZO
Carrizo Oil & Gas Inc
CRZO
|
+$770K |
| 4 |
BBQ
BBQ Holdings, Inc. Common Stock
BBQ
|
+$615K |
| 5 |
ENSV
Enservco Corp.
ENSV
|
+$557K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LeMaitre Vascular
LMAT
|
+$2.2M |
| 2 |
AVP
Avon Products, Inc.
AVP
|
+$1.27M |
| 3 |
CAB
Cabela's Inc
CAB
|
+$1.17M |
| 4 |
NeoGenomics
NEO
|
+$1.08M |
| 5 |
Medtronic
MDT
|
+$963K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 62.07% |
| 2 | Technology | 13.61% |
| 3 | Industrials | 8.76% |
| 4 | Consumer Staples | 4.76% |
| 5 | Energy | 3.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Axogen
AXGN
$2.77B
| $5.36M | 5.88% |
595,908
-25,000
| -4% | -$215K |
|
|
STJ
2
DELISTED
St Jude Medical
STJ
| $5.1M | 5.59% |
63,605
-3,068
| -5% | -$244K |
|
|
3
NeoGenomics
NEO
$2.32B
| $4.54M | 4.98% |
530,175
-125,625
| -19% | -$1.08M |
|
|
CSII
4
DELISTED
Cardiovascular Systems, Inc.
CSII
| $3.09M | 3.39% |
127,550
+15,950
| +14% | +$391K |
|
5
Rockwell Medical
RMTI
$32.9M
| $2.9M | 3.18% |
4,025
-5
| -0.1% | -$3.46K |
|
6
AtriCure
ATRC
$2.47B
| $2.5M | 2.74% |
127,750
+6,050
| +5% | +$110K |
|
7
Altimmune
ALT
$605M
| $2.3M | 2.52% |
2,360
-373
| -14% | -$334K |
|
8
Apyx Medical
APYX
$130M
| $2.27M | 2.49% |
632,035
-15,000
| -2% | -$66.8K |
|
|
SNAK
9
DELISTED
Inventure Foods, Inc.
SNAK
| $1.96M | 2.15% |
198,750
| – | – |
|
|
CGNT
10
DELISTED
Cogentix Medical, Inc.
CGNT
| $1.85M | 2.03% |
921,969
-57,641
| -6% | -$118K |
|
11
Pfizer
PFE
$159B
| $1.76M | 1.93% |
57,210
-369
| -0.6% | -$11.3K |
|
12
Idexx Laboratories
IDXX
$43.7B
| $1.64M | 1.8% |
14,000
| – | – |
|
13
Tactile Systems Technology
TCMD
$525M
| $1.59M | 1.74% |
96,961
| – | – |
|
14
Eli Lilly
LLY
$1.05T
| $1.45M | 1.59% |
19,700
| – | – |
|
15
Microsoft
MSFT
$3.81T
| $1.42M | 1.56% |
22,810
+350
| +2% | +$21.1K |
|
|
ATRS
16
DELISTED
Antares Pharma, Inc.
ATRS
| $1.41M | 1.55% |
607,000
| – | – |
|
|
ZIXI
17
DELISTED
Zix Corporation
ZIXI
| $1.39M | 1.52% |
280,989
-20,560
| -7% | -$90.8K |
|
18
IRIDEX
IRIX
$12.3M
| $1.36M | 1.49% |
96,500
+15,700
| +19% | +$223K |
|
|
ASRT
19
DELISTED
Assertio
ASRT
| $1.31M | 1.44% |
1,217
-51
| -4% | -$65K |
|
20
AT&T
T
$178B
| $1.2M | 1.31% |
37,286
| – | – |
|
|
SVU
21
DELISTED
SUPERVALU Inc.
SVU
| $1.19M | 1.31% |
36,521
-358
| -1% | -$11.9K |
|
|
VYNT
22
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $1.17M | 1.28% |
5,757
-7
| -0.1% | -$1.59K |
|
|
TEAR
23
DELISTED
TearLab Corporation
TEAR
| $1.14M | 1.25% |
218,418
+33,594
| +18% | +$191K |
|
|
24
Integer Holdings
ITGR
$4.26B
| $1.11M | 1.22% |
+37,800
| New | +$951K |
|
25
AbbVie
ABBV
$451B
| $1.1M | 1.2% |
17,525
-250
| -1% | -$15.3K |
|
Similar funds
AA
WA
AC
BCVI
SWM
HAP
RHIG
CWM
Perkins Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Perkins Capital Management held 120 positions worth $91.2M, down 8.8% from $100M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Perkins Capital Management withdrew a net $6.5M in Q4 2016, closing 16 positions and reducing 40 holdings. Its most notable exit was LeMaitre Vascular, an estimated $2.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 64% a quarter earlier, followed by Technology and Industrials.
Against the trend, Perkins Capital Management opened a new position in Ooma worth $994K.
- Perkins Capital Management's largest Q4 2016 buy was Ooma: 110,450 shares worth $994K.
- Perkins Capital Management added most to Xtant Medical Holdings in Q4 2016, an estimated $486K increase.
- Perkins Capital Management's biggest Q4 2016 reduction was NeoGenomics, cutting an estimated $1.08M.
- Perkins Capital Management fully exited LeMaitre Vascular in Q4 2016, selling an estimated $2.2M.
- Perkins Capital Management's ten largest holdings make up 35% of its $91.2M portfolio in Q4 2016.
- Perkins Capital Management opened 8 new positions and closed 16 in Q4 2016.
- Perkins Capital Management's portfolio value fell 8.8% quarter-over-quarter to $91.2M.
Based on Perkins Capital Management's 13F filing for Q4 2016, filed 1 Feb 2017.